BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 25960401)

  • 1. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
    Khan H; Greene SJ; Fonarow GC; Kalogeropoulos AP; Ambrosy AP; Maggioni AP; Zannad F; Konstam MA; Swedberg K; Yancy CW; Gheorghiade M; Butler J;
    Eur J Heart Fail; 2015 Oct; 17(10):1022-31. PubMed ID: 25960401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
    Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.
    Eapen ZJ; Reed SD; Li Y; Kociol RD; Armstrong PW; Starling RC; McMurray JJ; Massie BM; Swedberg K; Ezekowitz JA; Fonarow GC; Teerlink JR; Metra M; Whellan DJ; O'Connor CM; Califf RM; Hernandez AF
    Circ Heart Fail; 2013 Jul; 6(4):727-32. PubMed ID: 23770519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality.
    Reynolds K; Butler MG; Kimes TM; Rosales AG; Chan W; Nichols GA
    Am J Cardiol; 2015 Aug; 116(3):400-5. PubMed ID: 26037295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure.
    Sud M; Yu B; Wijeysundera HC; Austin PC; Ko DT; Braga J; Cram P; Spertus JA; Domanski M; Lee DS
    JACC Heart Fail; 2017 Aug; 5(8):578-588. PubMed ID: 28501521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors determining post-operative readmissions after left ventricular assist device implantation.
    Tsiouris A; Paone G; Nemeh HW; Brewer RJ; Morgan JA
    J Heart Lung Transplant; 2014 Oct; 33(10):1041-7. PubMed ID: 25034795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry.
    Di Tano G; De Maria R; Gonzini L; Aspromonte N; Di Lenarda A; Feola M; Marini M; Milli M; Misuraca G; Mortara A; Oliva F; Pulignano G; Russo G; Senni M; Tavazzi L;
    Eur J Heart Fail; 2015 Oct; 17(10):1032-41. PubMed ID: 26018852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International variation in and factors associated with hospital readmission after myocardial infarction.
    Kociol RD; Lopes RD; Clare R; Thomas L; Mehta RH; Kaul P; Pieper KS; Hochman JS; Weaver WD; Armstrong PW; Granger CB; Patel MR
    JAMA; 2012 Jan; 307(1):66-74. PubMed ID: 22215167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial.
    Chiong JR; Kim S; Lin J; Christian R; Dasta JF
    J Med Econ; 2012; 15(2):276-84. PubMed ID: 22111754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure.
    Habal MV; Liu PP; Austin PC; Ross HJ; Newton GE; Wang X; Tu JV; Lee DS
    Circ Heart Fail; 2014 Jan; 7(1):12-20. PubMed ID: 24297690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
    Blair JE; Zannad F; Konstam MA; Cook T; Traver B; Burnett JC; Grinfeld L; Krasa H; Maggioni AP; Orlandi C; Swedberg K; Udelson JE; Zimmer C; Gheorghiade M;
    J Am Coll Cardiol; 2008 Nov; 52(20):1640-8. PubMed ID: 18992654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients.
    Schrager J; Wheatley M; Georgiopoulou V; Osborne A; Kalogeropoulos A; Hung O; Butler J; Ross M
    Acad Emerg Med; 2013 Jun; 20(6):554-61. PubMed ID: 23758301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors Associated With 7- Versus 30-Day Readmission Among Patients With Heart Failure Using the Nationwide Readmission Database.
    Pham PN; Xiao H; Sarayani A; Chen M; Brown JD
    Med Care; 2019 Jan; 57(1):1-7. PubMed ID: 30363021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
    Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
    Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of early readmission after hospitalization for heart failure.
    Eastwood CA; Howlett JG; King-Shier KM; McAlister FA; Ezekowitz JA; Quan H
    Can J Cardiol; 2014 Jun; 30(6):612-8. PubMed ID: 24882531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days.
    Kociol RD; Liang L; Hernandez AF; Curtis LH; Heidenreich PA; Yancy CW; Fonarow GC; Peterson ED
    Am Heart J; 2013 Jun; 165(6):987-994.e1. PubMed ID: 23708171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
    O'Connor CM; Miller AB; Blair JE; Konstam MA; Wedge P; Bahit MC; Carson P; Haass M; Hauptman PJ; Metra M; Oren RM; Patten R; Piña I; Roth S; Sackner-Bernstein JD; Traver B; Cook T; Gheorghiade M;
    Am Heart J; 2010 May; 159(5):841-849.e1. PubMed ID: 20435194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.
    Samsky MD; Ambrosy AP; Youngson E; Liang L; Kaul P; Hernandez AF; Peterson ED; McAlister FA
    JAMA Cardiol; 2019 May; 4(5):444-453. PubMed ID: 30969316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital readmissions of patients with heart failure: the impact of hospital and primary care organizational factors in Northern Italy.
    Avaldi VM; Lenzi J; Castaldini I; Urbinati S; Di Pasquale G; Morini M; Protonotari A; Maggioni AP; Fantini MP
    PLoS One; 2015; 10(5):e0127796. PubMed ID: 26010223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer-than-average length of stay in acute heart failure : Determinants and outcomes.
    Omar HR; Guglin M
    Herz; 2018 Mar; 43(2):131-139. PubMed ID: 28168428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.